CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
Cognitive behavioral therapybehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02265588
NCT02265588N/ACompleted

Reducing Symptoms of Depression and Anxiety in Adolescents With Inflammatory Bowel Disease in Order to Improve Quality of Life and the Clinical Course of Disease.

Erasmus Medical Center·interventional·Posted Oct 16, 2014·Updated Jul 28, 2022

In Brief

A clinical study evaluating Cognitive behavioral therapy for Inflammatory Bowel Disease (IBD) and 4 related conditions. Completed, enrolled 70 participants across 1 site.

Detailed Summary

The presented study aims to reduce symptoms of depression and anxiety in adolescents with inflammatory bowel disease and increased symptoms of anxiety and depression by using the disease specific CBT program (PASCET-PI)in order to improve quality of life and to improve the clinical course of disease.

Study Details

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 16, 2014
Enrollment StartSep 1, 2014
Primary CompletionOct 1, 2016
Study CompletionAug 24, 2017
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 11.7 years ago

Interventions

Cognitive behavioral therapybehavioral

A disease specific cognitive behavioral therapy program called PASCET-PI: The PASCET-PI model focuses on behavioral activation, cognitive restructuring and problem solving skills to change maladaptive behaviors, cognitions and coping strategies specific for IBD.